Colgate Stock Jumps on an Earnings Beat — and Raises Its 2026 Outlook

Colgate-Palmolive stock rose on Friday, October 30, 2026, after the consumer staples giant beat third-quarter earnings and sales estimates and raised its full-year 2026 profit outlook. On a day when technology shares were sliding sharply, Colgate was one of the market's defensive winners: its Base Business earnings rose 7% to $0.97 per share, net sales grew 4.6% to $5.37 billion, and management lifted its 2026 Base Business earnings growth guidance to 5% to 7%.

What happened

Colgate-Palmolive reported third-quarter 2026 results before the market opened on Friday. Base Business (non-GAAP) earnings per share came in at $0.97, up 7% from a year earlier and ahead of consensus estimates of roughly $0.92 to $0.93 per share. GAAP earnings per share rose 3% to $0.94. Net sales increased 4.6% to $5.37 billion, beating the consensus mark of about $5.33 billion, while organic sales rose 3.6%.

Profitability improved even as costs stayed high. GAAP gross profit margin expanded 80 basis points to 60.2%, and Base Business gross margin rose 90 basis points to 60.3%. Net cash provided by operations totaled $2.913 billion for the first nine months of 2026. Shares responded quickly: the stock traded at $95.51, up 2.52%, late on Friday morning, and featured among the day's notable gainers in earnings roundups while the broader tech sector sold off.

The guidance raise, in full

The headline for investors was not just the beat — it was the outlook. Colgate narrowed its 2026 net sales growth guidance to 4% to 5%, from a wider 2% to 6% range previously. It raised its Base Business earnings per share growth guidance to 5% to 7%, replacing its earlier mid-single-digit expectation, and it now expects gross profit margin to grow year over year rather than stay roughly flat. Management also maintained expectations for double-digit GAAP earnings growth. In plain terms: the company is telling investors the second half of the year looks better than it did three months ago, on both sales and profit.

Why it is blowing up

Three things made this report travel. First, timing: Colgate reported into a risk-off session dominated by a semiconductor and AI selloff, so a clean beat-and-raise from a toothpaste and soap maker stood out as the market's safe-haven trade of the day. Second, consistency: growth was broad, with net sales and organic sales increasing in all four product categories and in four of five geographic divisions. Third, pricing power: Colgate said it still holds a 41.4% global market share in toothpaste, and its margin expansion shows it is passing through costs without losing shoppers — the exact quality investors pay a premium for when inflation worries return.

The weak spot: North America

The report was not flawless. North American net sales fell 1.7%, with organic sales down 1.6% and volume down 3.7% — the clearest soft patch in the quarter. Management also flagged that raw material and packaging costs remain a significant headwind, particularly resins and petrochemicals, as well as pulp and paper, with roughly $300 million of cost inflation in the original plan. The offset, executives said, is that cost projections for the rest of 2026 are now largely locked in, which is part of why the company felt confident enough to raise the earnings range.

Key facts

• Q3 2026 Base Business EPS: $0.97, up 7% year over year, beating consensus of about $0.92–$0.93.
• Net sales: $5.37 billion, up 4.6%; organic sales up 3.6%.
• GAAP EPS: $0.94, up 3%; GAAP gross margin 60.2%, up 80 basis points.
• 2026 guidance: sales growth narrowed to 4%–5%; Base Business EPS growth raised to 5%–7%.
• North America sales fell 1.7% — the quarter's main weak spot.
• Operating cash flow for the first nine months of 2026: $2.913 billion.

What's next

The next test is the fourth quarter: whether North American volumes stabilize and whether the locked-in cost assumptions hold if oil-linked input prices stay elevated. For now, Colgate has done what few companies managed this earnings season — beaten estimates, raised guidance, and expanded margins at the same time. This report describes what happened and how markets reacted; it is not a recommendation to buy, sell, or hold any security.

Sources

• Business Wire — Colgate-Palmolive Announces 3rd Quarter 2026 Results
• Zacks — Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains
• Finimize — Colgate-Palmolive Raised Its 2026 Earnings Outlook After a Beat
• Seeking Alpha — Colgate-Palmolive Non-GAAP EPS of $0.97 beats by $0.04, revenue of $5.37B beats by $40M

FAQ

Did Colgate-Palmolive beat earnings estimates in Q3 2026?

Yes. Base Business earnings per share were $0.97, up 7% year over year and ahead of consensus estimates of about $0.92 to $0.93, while net sales of $5.37 billion also topped expectations.

What guidance did Colgate raise for 2026?

Colgate raised its Base Business EPS growth outlook to 5% to 7% from mid-single-digit growth, narrowed sales growth guidance to 4% to 5%, and now expects gross margin to expand rather than stay roughly flat.

Why did Colgate stock rise on October 30, 2026?

The stock rose after the earnings beat and guidance raise, and it stood out as a defensive winner on a day when technology and semiconductor shares were selling off sharply.

What was the weak spot in Colgate's quarter?

North America. Regional net sales fell 1.7%, organic sales fell 1.6%, and volume fell 3.7%, while resin, petrochemical, pulp and paper costs remained a headwind.